Martin Digglemann

Title: Martin Digglemann: Innovator in Enzymatic Discrimination Enhancement

Introduction

Martin Digglemann is a notable inventor based in Niederdorf, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the area of enzymatic discrimination enhancement. His work has implications for pharmaceutical discovery and biological sample screening.

Latest Patents

Martin Digglemann holds a patent titled "Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA." This patent focuses on methods for discriminating between fully complementary hybrids and those that differ by one or more base pairs. It also includes libraries of unimolecular, double-stranded oligonucleotides on a solid support. The invention provides methods of using nuclease treatment to improve the quality of hybridization signals on high-density oligonucleotide arrays. Additionally, it offers methods of using ligation reactions to enhance hybridization signals. The libraries created through this invention are useful in pharmaceutical discovery for screening biological samples for specific interactions between double-stranded oligonucleotides, peptides, proteins, drugs, and RNA.

Career Highlights

Martin Digglemann is associated with Affymetrix, Inc., a company known for its innovations in genetic analysis and biotechnology. His work at Affymetrix has allowed him to contribute to advancements in high-density oligonucleotide arrays and related technologies.

Collaborations

Throughout his career, Martin has collaborated with notable professionals in the field, including David J Lockhart and Mark S Chee. These collaborations have furthered the development of innovative solutions in biotechnology.

Conclusion

Martin Digglemann's contributions to enzymatic discrimination enhancement and his innovative patent work have positioned him as a key figure in biotechnology. His efforts continue to influence pharmaceutical discovery and biological research.